Walter Perkins, Ph.D.
Chief Technology Officer
Walter joined Insmed in December 2010 in connection with the business combination between Insmed and Transave. Prior to this, Walter joined Transave in 2002 and served as Chief Technology Officer. Walter has over 20 years experience utilizing lipid-based drug delivery systems and has authored over 55 scientific publications and patent applications. Prior to joining Transave, Walter spent 15 years with The Liposome Company (later a part of Elan Drug Delivery). At The Liposome Company, Walter was involved in the design of several lipid-based drug delivery systems, including an artificial lung surfactant formulation, and helped in the characterization, development and launch of the company's two commercial products Abelcet® and Myocet®. As a part of Elan's Drug Delivery Division, he played a lead role in the implementation of liposome technology in both inter-divisional projects and corporate partnerships. Walter received his bachelor's and doctoral degrees in Biophysical Chemistry from the University of Virginia where he studied the physical and electrical properties of liposomal membranes.
